Bayer advances combined seed and crop protection pipeline and enters phase of blockbuster launches
Huxley, Iowa, September 2, 2026 – Bayer is implementing its previously announced ambition to bring 10 blockbusters to…
Jana Marlen Ackermann to be new Head of Investor Relations at Bayer
The following materials are not directed at or to be accessed by persons located in the United
…
Bayer operationally on track, decisive progress on strategic priorities
Leverkusen, August 4, 2026 – The Bayer Group continued to make headway in the second quarter of 2026,…
Bayer submits application for next indication of Kerendia in China
Berlin, July 30, 2026 – Bayer today announced the submission of a New Drug Application to the Center…
Bayer completes acquisition of Perfuse Therapeutics
The following materials are not directed at or to be accessed by persons located in the United
…
Bayer successfully places new U.S. dollar bonds with a volume of 5 billion
The following materials are not directed at or to be accessed by persons located in the United
…
Bayer signs licensing agreement with RAGT and begins broad hybrid wheat commercialization by early 2030s
The following materials are not directed at or to be accessed by persons located in the United
…
Bayer secures 3.0 billion euros to improve capital structure
The following materials are not directed at or to be accessed by persons located in the United
…
Bayer secures 3.0 billion euros to improve capital structure
The following materials are not directed at or to be accessed by persons located in the United
…
Bayer Group to consolidate U.S. glyphosate business into distinct entity operating as Ruveon
The following materials are not directed at or to be accessed by persons located in the United
…
Monsanto wins landmark Roundup™ case at U.S. Supreme Court
Leverkusen, June 25, 2026 – The U.S. Supreme Court issued a 7:2 landmark ruling in the Durnell Roundup™…
European Medicines Agency confirms Bayer’s FXIa inhibitor marketing authorization application for assessment in secondary prevention of ischemic stroke
Not intended for U.S. and UK Media European Medicines Agency confirms asundexian marketing authorization application for assessment…